CXCR4/CXCL12 also facilitates the homing of tumour cells to distal organs while limiting therapeutic effectiveness due to protecting tumour cells from immune attack and apoptosis, making it an important therapeutic target [58]. The gene discussed is CXCR4; the disease is neoplasm.